Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidolCUBEDDU, L. X; HOFFMANN, I. S; JAMES, M. K et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 226, Num 3, pp 680-685, issn 0022-3565Article

BROMOCRIPTINTHERAPIE = BROMOCRIPTINEKOENIG MP.1981; SCHWEIZ. MED. WOCHENSCHR.; ISSN 0036-7672; CHE; DA. 1981; VOL. 111; NO 9; PP. 303-308; ABS. ENG; BIBL. 18 REF.Article

Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine : case report. CommentaryKAWABATA, Yasuhiro; UENO, Yasushi; HORIKAWA, Fumihiko et al.Surgical neurology. 2008, Vol 69, Num 1, pp 85-88, issn 0090-3019, 4 p.Article

Superiority of newly developed vaginal suppositories over vaginal use of commercial bromocriptine tablets: A randomized controlled clinical trialDARWISH, Atef M; FARAH, Emad; GADALLAH, Wafaa A et al.Reproductive sciences (Thousand Oaks, Calif.). 2007, Vol 14, Num 3, pp 280-285, issn 1933-7191, 6 p.Article

Differential pulse voltammetric determination of the dopaminergic agonist bromocriptine at glassy carbon electrodeRADI, A; EL-SHAHAWI, M. S; ELMOGY, T et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 195-198, issn 0731-7085, 4 p.Article

Cardiomyopathie du péripartum : La femme enceinte et le cardiologue = Peripartum cardiomyopathyMOUQUET, F.La Lettre du cardiologue. 2012, Num 458, pp 14-18, issn 0761-5035, 5 p.Article

Giant prolactinoma: Where's the prolactin?TAILOR, Chetna; TEO, Iris; SORISKY, Alexander et al.Clinical neurology and neurosurgery (Dutch-Flemish ed.). 2011, Vol 113, Num 9, pp 810-812, issn 0303-8467, 3 p.Article

Enzyme immunoassays for bromocriptine and its metabolitesVALENTE, D; EZAN, E; CREMINON, C et al.Journal of immunoassay. 1996, Vol 17, Num 4, pp 297-320, issn 0197-1522Article

Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgiaKILICDAG, E. B; TARIM, E; BAGIS, T et al.International journal of gynaecology and obstetrics. 2004, Vol 85, Num 3, pp 292-293, issn 0020-7292, 2 p.Article

Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus : results of a long-term follow upZHE BAO WU; CHUN JIANG YU; ZHI PENG SU et al.Journal of neurosurgery. 2006, Vol 104, Num 1, pp 54-61, issn 0022-3085, 8 p.Article

Prolactin-secreting tumors : what's new?MOLITCH, Mark E.Expert review of anticancer therapy. 2006, Vol 6, Num 9, issn 1473-7140, S29-S35, SUPArticle

Transdermal administration of bromocriptineISMAIL TUNCER DEGIM; ACARTÜRK, Füsun; ERDOGAN, Deniz et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 4, pp 501-505, issn 0918-6158, 5 p.Article

Prolactin-mediated regulation of lipid biosynthesis genes in vivo in the lactating mammary epithelial cellRUDOLPH, Michael C; RUSSELL, Tanya D; WEBB, Patricia et al.American journal of physiology. Endocrinology and metabolism. 2011, Vol 63, Num 6, issn 0193-1849, E1059-E1068Article

Blockage of ghrelin-induced prolactin secretion in women by bromocriptineMESSINI, Christina I; DAFOPOULOS, Konstantinos; CHALVATZAS, Nektarios et al.Fertility and sterility. 2010, Vol 94, Num 4, pp 1478-1481, issn 0015-0282, 4 p.Article

Efficacy and safety of bromocriptine in the treatment of macroprolactinomasESSAÏS, O; BOUGUERRA, R; HAMZAOUI, J et al.Annales d'endocrinologie. 2002, Vol 63, Num 6, pp 524-531, issn 0003-4266, 8 p., 1Article

Levodopa and bromocriptine in hypoxic brain injuryDEBETTE, Stéphanie; KOZLOWSKI, Odile; STEINLING, Marc et al.Journal of neurology. 2002, Vol 249, Num 12, pp 1678-1682, issn 0340-5354, 5 p.Article

Low-dose bromocriptine therapy in Parkinson's diseasePFEIFFER, R. F; WILKEN, K; GLAESKE, C et al.Archives of neurology (Chicago). 1985, Vol 42, Num 6, pp 586-588, issn 0003-9942Article

Bromocriptine-responsive idiopathic edemaZIMLICHMAN, R. R; PORATH, A; SOBEL, R et al.Israel journal of medical sciences. 1984, Vol 20, Num 3, pp 264-266, issn 0021-2180Article

Primary tissue culture of human adrenocortical Conn's adenomata: bromocriptine as a possible agonist-antagonist of angiotensin at the cellular levelARMATO, U; MANTERO, F.Cell and tissue research. 1984, Vol 236, Num 1, pp 67-72, issn 0302-766XArticle

Severity of Parkinsońs disease and the dosage of bromocriptineLARSEN, T. A; NEWMAN, R; LEWITT, P et al.Neurology. 1984, Vol 34, Num 6, pp 795-797, issn 0028-3878Article

Essai de la bromocriptine dans le traitement de l'autisme infantile = Use of bromocriptene in child autism treatmentSIMON-SORET, C; BORENSTEIN, P.La Presse médicale (1983). 1987, Vol 16, Num 26, issn 0755-4982, 1286Article

Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolideGOETZ, C. G; TANNER, C. M; GLANTZ, R. H et al.Neurology. 1985, Vol 35, Num 5, pp 749-751, issn 0028-3878Article

Bromocriptine in the management of end of dose deterioration in Parkinson's diseaseGRIMES, J. D; KING, D. B; KOFMAN, O. S et al.Canadian journal of neurological sciences. 1984, Vol 11, Num 4, pp 452-456, issn 0317-1671Article

Syndromes dépressifs en gériatrie: intérêt de l'association clomipramine-bromocriptine = Depression in geriatry: advantage of the association clomipramine-bromocriptineBROCKER, P; BENSENIOR, H; LODS, J. C et al.La Revue de gériatrie. 1983, Vol 8, Num 8, pp 385-388, issn 0397-7927Article

Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymesJU HEE LIM; SA SUK KIM; DOO HYUN BOO et al.Neuroscience letters. 2009, Vol 451, Num 3, pp 185-189, issn 0304-3940, 5 p.Article